ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 134 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,126,000 | -36.0% | 2,100,000 | -10.0% | 1.70% | -26.3% |
| Q2 2023 | $65,842,140 | +30.7% | 2,334,000 | -20.3% | 2.30% | +37.6% |
| Q1 2023 | $50,383,960 | -51.4% | 2,929,300 | -43.1% | 1.67% | -25.6% |
| Q4 2022 | $103,721,000 | +13.4% | 5,150,000 | +21.9% | 2.25% | +20.8% |
| Q3 2022 | $91,472,000 | -9.2% | 4,223,100 | +17.8% | 1.86% | -19.6% |
| Q2 2022 | $100,763,000 | -31.3% | 3,585,881 | +12.9% | 2.31% | -24.2% |
| Q1 2022 | $146,587,000 | -35.8% | 3,176,999 | +17.0% | 3.05% | -36.9% |
| Q4 2021 | $228,223,000 | +37.3% | 2,715,000 | +8.9% | 4.84% | +31.5% |
| Q3 2021 | $166,187,000 | +44.6% | 2,493,800 | +15.5% | 3.68% | +18.5% |
| Q2 2021 | $114,912,000 | +109.6% | 2,160,000 | +71.0% | 3.11% | +105.2% |
| Q1 2021 | $54,815,000 | -7.0% | 1,263,300 | +11.3% | 1.51% | -20.9% |
| Q4 2020 | $58,952,000 | +99.5% | 1,135,000 | +25.5% | 1.91% | +39.6% |
| Q3 2020 | $29,556,000 | -8.7% | 904,119 | +34.0% | 1.37% | -34.0% |
| Q2 2020 | $32,389,000 | – | 674,487 | – | 2.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,426,095 | $111,940,000 | 6.63% |
| Paradigm Biocapital Advisors LP | 287,577 | $13,269,000 | 3.51% |
| Avidity Partners Management LP | 3,176,999 | $146,587,000 | 3.05% |
| Integral Health Asset Management, LLC | 215,000 | $9,920,000 | 2.58% |
| Matrix Capital Management Company, LP | 4,349,279 | $200,676,000 | 2.41% |
| Affinity Asset Advisors, LLC | 207,500 | $9,574,000 | 1.53% |
| Ikarian Capital, LLC | 202,203 | $9,329,000 | 1.23% |
| Ghost Tree Capital, LLC | 80,000 | $3,691,000 | 0.80% |
| Eventide Asset Management | 761,000 | $35,113,000 | 0.55% |
| Perceptive Advisors | 501,509 | $23,140,000 | 0.46% |